Dr. Lauri Wagter-Lesperance, PhD

Director of Operations, Regulatory Affairs & Quality Assurance | Co-Inventor, HIR™ Technology

Dr. Lauraine Wagter-Lesperance is a Senior Research Associate in Immunology and Genetics/Genomics at the University of Guelph, and Director of Operations, Regulatory Affairs and Quality Assurance at ImmunoCeutica Inc. She is a co-inventor of the patented High Immune Response (HIR™) Technology, the scientific foundation of Immunity+™, marketed in over 120 countries by Semex Alliance.

Dr. Wagter-Lesperance holds graduate training in immunology, genetics, genomics, epidemiology, and biostatistics, complemented by applied expertise in regulatory affairs, technology transfer, commercialization, and knowledge translation. She has conducted research in both human medical and veterinary contexts, including provincial-level epidemiological research on genetic predisposition to cancer at the Alberta Cancer Board (now Alberta Health Services).

At ImmunoCeutica, Dr. Wagter-Lesperance oversees operations, regulatory compliance, and quality assurance, ensuring that the company's products and scientific communications meet the highest standards of accuracy, integrity, and evidence-based practice.